| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myotonic Dystrophy | 36 | 2023 | 151 | 4.380 |
Why?
|
| Myotonic Disorders | 9 | 2013 | 13 | 1.290 |
Why?
|
| DNA Repeat Expansion | 4 | 2017 | 64 | 0.830 |
Why?
|
| Trinucleotide Repeat Expansion | 7 | 2023 | 132 | 0.680 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 2 | 2015 | 113 | 0.600 |
Why?
|
| Mesoderm | 2 | 2015 | 404 | 0.550 |
Why?
|
| DNA Methylation | 6 | 2021 | 2669 | 0.540 |
Why?
|
| DNA | 6 | 2023 | 2693 | 0.510 |
Why?
|
| RNA-Binding Proteins | 6 | 2010 | 984 | 0.500 |
Why?
|
| Bone and Bones | 2 | 2015 | 619 | 0.500 |
Why?
|
| Skull | 1 | 2015 | 231 | 0.450 |
Why?
|
| Alternative Splicing | 8 | 2020 | 584 | 0.450 |
Why?
|
| Myotonin-Protein Kinase | 8 | 2023 | 36 | 0.430 |
Why?
|
| Li-Fraumeni Syndrome | 3 | 2011 | 158 | 0.410 |
Why?
|
| Chromosome Mapping | 14 | 2005 | 1471 | 0.410 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 4 | 2008 | 362 | 0.400 |
Why?
|
| Trinucleotide Repeats | 3 | 2020 | 106 | 0.390 |
Why?
|
| Founder Effect | 6 | 2004 | 42 | 0.380 |
Why?
|
| Gene Frequency | 4 | 2011 | 1163 | 0.370 |
Why?
|
| Base Sequence | 17 | 2011 | 4917 | 0.360 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 1498 | 0.330 |
Why?
|
| Muscle, Skeletal | 10 | 2017 | 1270 | 0.330 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2011 | 4549 | 0.330 |
Why?
|
| Mutation | 24 | 2016 | 15179 | 0.320 |
Why?
|
| RNA Precursors | 1 | 2008 | 137 | 0.310 |
Why?
|
| Microsatellite Repeats | 4 | 2009 | 575 | 0.300 |
Why?
|
| Gene Expression Profiling | 7 | 2010 | 5159 | 0.300 |
Why?
|
| Alleles | 10 | 2023 | 2437 | 0.290 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 622 | 0.290 |
Why?
|
| Genome, Human | 4 | 2009 | 1869 | 0.270 |
Why?
|
| Genomic Instability | 1 | 2009 | 519 | 0.270 |
Why?
|
| Molecular Sequence Data | 20 | 2011 | 6089 | 0.270 |
Why?
|
| Chromosomes, Human, Pair 3 | 3 | 2003 | 311 | 0.270 |
Why?
|
| Chromosomes, Human, Pair 19 | 6 | 1997 | 143 | 0.260 |
Why?
|
| Papillomaviridae | 1 | 2009 | 624 | 0.260 |
Why?
|
| RNA, Neoplasm | 1 | 2008 | 771 | 0.260 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 11 | 2015 | 3639 | 0.260 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2005 | 327 | 0.260 |
Why?
|
| Restriction Mapping | 3 | 2003 | 264 | 0.250 |
Why?
|
| Muscular Dystrophies | 3 | 2013 | 51 | 0.250 |
Why?
|
| Head and Neck Neoplasms | 2 | 2009 | 3976 | 0.230 |
Why?
|
| X Chromosome | 2 | 2002 | 339 | 0.230 |
Why?
|
| Osteogenesis | 2 | 2015 | 271 | 0.230 |
Why?
|
| Family Health | 1 | 2004 | 325 | 0.230 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2009 | 5437 | 0.220 |
Why?
|
| Biopsy | 4 | 2008 | 3443 | 0.220 |
Why?
|
| CpG Islands | 3 | 2003 | 633 | 0.210 |
Why?
|
| Receptors, Vasoactive Intestinal Peptide | 1 | 2001 | 2 | 0.210 |
Why?
|
| Mouth Mucosa | 1 | 2023 | 216 | 0.210 |
Why?
|
| DNA Primers | 6 | 2009 | 1399 | 0.200 |
Why?
|
| Germ-Line Mutation | 3 | 2011 | 1046 | 0.200 |
Why?
|
| Glioblastoma | 2 | 2011 | 1797 | 0.200 |
Why?
|
| RNA, Messenger | 7 | 2020 | 6150 | 0.200 |
Why?
|
| Humans | 81 | 2023 | 261506 | 0.200 |
Why?
|
| Body Height | 1 | 2002 | 231 | 0.190 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 2 | 2011 | 36 | 0.190 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 2 | 2011 | 55 | 0.190 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2018 | 3552 | 0.190 |
Why?
|
| Genetic Testing | 1 | 2008 | 1589 | 0.180 |
Why?
|
| Transcription Factors | 8 | 2015 | 5270 | 0.180 |
Why?
|
| Loss of Heterozygosity | 3 | 2009 | 602 | 0.180 |
Why?
|
| Haplotypes | 8 | 2011 | 856 | 0.180 |
Why?
|
| RNA Splicing | 4 | 2017 | 370 | 0.180 |
Why?
|
| Trisomy | 1 | 2001 | 231 | 0.180 |
Why?
|
| Muscular Atrophy | 3 | 2017 | 105 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2001 | 317 | 0.180 |
Why?
|
| Pedigree | 8 | 2011 | 1890 | 0.170 |
Why?
|
| Sp7 Transcription Factor | 2 | 2015 | 27 | 0.160 |
Why?
|
| Mosaicism | 1 | 2020 | 272 | 0.160 |
Why?
|
| Anemia, Megaloblastic | 4 | 2004 | 10 | 0.160 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2020 | 2508 | 0.160 |
Why?
|
| Sequence Analysis, DNA | 5 | 2003 | 2483 | 0.160 |
Why?
|
| Saliva | 1 | 2019 | 231 | 0.160 |
Why?
|
| Immunohistochemistry | 8 | 2015 | 7548 | 0.160 |
Why?
|
| Polymerase Chain Reaction | 12 | 2019 | 3203 | 0.150 |
Why?
|
| Caudate Nucleus | 1 | 2017 | 43 | 0.150 |
Why?
|
| Blotting, Western | 6 | 2015 | 3536 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2011 | 5539 | 0.150 |
Why?
|
| Retinoids | 1 | 2018 | 164 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2011 | 507 | 0.150 |
Why?
|
| Tissue Distribution | 4 | 2010 | 875 | 0.150 |
Why?
|
| Exons | 7 | 2013 | 1328 | 0.150 |
Why?
|
| Genetic Loci | 1 | 2019 | 481 | 0.140 |
Why?
|
| Behavior, Addictive | 1 | 2017 | 99 | 0.140 |
Why?
|
| Male | 38 | 2020 | 123000 | 0.140 |
Why?
|
| Female | 43 | 2020 | 141928 | 0.140 |
Why?
|
| Osteoblasts | 2 | 2015 | 370 | 0.140 |
Why?
|
| Leukemia, Myeloid | 1 | 2001 | 941 | 0.140 |
Why?
|
| Transcription, Genetic | 5 | 2008 | 3154 | 0.140 |
Why?
|
| Neuroglia | 1 | 2017 | 223 | 0.140 |
Why?
|
| Pathology, Molecular | 1 | 2016 | 128 | 0.130 |
Why?
|
| Protein Biosynthesis | 2 | 2010 | 889 | 0.130 |
Why?
|
| Gene Expression | 7 | 2013 | 3570 | 0.130 |
Why?
|
| RNA | 3 | 2017 | 1013 | 0.130 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2015 | 630 | 0.130 |
Why?
|
| Chondrocytes | 1 | 2015 | 107 | 0.130 |
Why?
|
| Muscle Proteins | 3 | 2007 | 549 | 0.120 |
Why?
|
| Europe | 2 | 2008 | 649 | 0.120 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2014 | 60 | 0.120 |
Why?
|
| Neoplasms, Experimental | 1 | 2018 | 750 | 0.120 |
Why?
|
| Intellectual Disability | 1 | 2002 | 1032 | 0.120 |
Why?
|
| Age of Onset | 5 | 2020 | 827 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2018 | 8873 | 0.120 |
Why?
|
| DNA Mutational Analysis | 7 | 2019 | 2283 | 0.120 |
Why?
|
| Tamoxifen | 1 | 2018 | 876 | 0.120 |
Why?
|
| Multigene Family | 3 | 2001 | 425 | 0.120 |
Why?
|
| MADS Domain Proteins | 3 | 2010 | 10 | 0.120 |
Why?
|
| Myogenic Regulatory Factors | 3 | 2010 | 35 | 0.110 |
Why?
|
| Microarray Analysis | 2 | 2013 | 392 | 0.110 |
Why?
|
| Receptors, Cell Surface | 4 | 2004 | 862 | 0.110 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2015 | 347 | 0.110 |
Why?
|
| Genetic Linkage | 3 | 2005 | 512 | 0.110 |
Why?
|
| Brain Neoplasms | 2 | 2008 | 4849 | 0.110 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2010 | 5319 | 0.110 |
Why?
|
| Gene Expression Regulation | 5 | 2015 | 4053 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 769 | 0.110 |
Why?
|
| Homeostasis | 1 | 2017 | 950 | 0.110 |
Why?
|
| Cell Line | 4 | 2015 | 5114 | 0.100 |
Why?
|
| Chromosomes, Artificial, Bacterial | 2 | 2002 | 129 | 0.100 |
Why?
|
| Phenotype | 9 | 2020 | 6295 | 0.100 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2010 | 116 | 0.100 |
Why?
|
| Neoplasm Proteins | 4 | 2009 | 3230 | 0.100 |
Why?
|
| Calcium-Binding Proteins | 3 | 2013 | 545 | 0.100 |
Why?
|
| Myotonia Congenita | 1 | 2010 | 6 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2014 | 854 | 0.100 |
Why?
|
| Drosophila melanogaster | 1 | 2017 | 829 | 0.100 |
Why?
|
| Finland | 6 | 2011 | 55 | 0.090 |
Why?
|
| Endopeptidases | 1 | 2011 | 220 | 0.090 |
Why?
|
| Adult | 22 | 2017 | 77950 | 0.090 |
Why?
|
| DNA, Complementary | 4 | 2013 | 869 | 0.090 |
Why?
|
| Gene Deletion | 1 | 2015 | 1442 | 0.090 |
Why?
|
| Myosins | 1 | 2010 | 96 | 0.090 |
Why?
|
| Neuroectodermal Tumors, Primitive | 2 | 2001 | 100 | 0.090 |
Why?
|
| Untranslated Regions | 1 | 2009 | 15 | 0.090 |
Why?
|
| DNA, Z-Form | 1 | 2009 | 2 | 0.090 |
Why?
|
| Models, Genetic | 3 | 2020 | 1113 | 0.090 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 2265 | 0.080 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2009 | 69 | 0.080 |
Why?
|
| Protein Isoforms | 4 | 2013 | 842 | 0.080 |
Why?
|
| Fibromyalgia | 1 | 2008 | 12 | 0.080 |
Why?
|
| Polymorphism, Genetic | 6 | 2011 | 1450 | 0.080 |
Why?
|
| Alu Elements | 1 | 2009 | 88 | 0.080 |
Why?
|
| Muscles | 4 | 2020 | 416 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2001 | 402 | 0.080 |
Why?
|
| Chloride Channels | 1 | 2008 | 60 | 0.080 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 4143 | 0.080 |
Why?
|
| Animals | 16 | 2018 | 59536 | 0.080 |
Why?
|
| Frozen Sections | 1 | 2008 | 105 | 0.080 |
Why?
|
| Apoptosis | 2 | 2017 | 7591 | 0.080 |
Why?
|
| Smoking | 1 | 2017 | 2440 | 0.080 |
Why?
|
| Cloning, Molecular | 5 | 2001 | 1213 | 0.080 |
Why?
|
| Down-Regulation | 2 | 2010 | 2074 | 0.080 |
Why?
|
| Genes, BRCA1 | 2 | 2001 | 387 | 0.080 |
Why?
|
| Troponin T | 1 | 2010 | 261 | 0.080 |
Why?
|
| Breast Neoplasms | 7 | 2009 | 15694 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 11538 | 0.080 |
Why?
|
| Epilepsies, Myoclonic | 2 | 1998 | 28 | 0.080 |
Why?
|
| Myasthenic Syndromes, Congenital | 1 | 2007 | 1 | 0.080 |
Why?
|
| Minisatellite Repeats | 2 | 1998 | 51 | 0.080 |
Why?
|
| Terminology as Topic | 1 | 2000 | 414 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 2054 | 0.080 |
Why?
|
| Physical Chromosome Mapping | 3 | 2002 | 73 | 0.080 |
Why?
|
| Glioma | 2 | 2009 | 1963 | 0.070 |
Why?
|
| Genotype | 6 | 2015 | 4109 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2015 | 4078 | 0.070 |
Why?
|
| Amino Acid Sequence | 7 | 2001 | 4233 | 0.070 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2008 | 182 | 0.070 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2007 | 136 | 0.070 |
Why?
|
| Middle Aged | 19 | 2014 | 86204 | 0.070 |
Why?
|
| Blotting, Southern | 5 | 2001 | 406 | 0.070 |
Why?
|
| Calcium | 1 | 2013 | 1537 | 0.070 |
Why?
|
| Cell Proliferation | 3 | 2015 | 7226 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 849 | 0.070 |
Why?
|
| Vitamin B 12 Deficiency | 2 | 2004 | 53 | 0.070 |
Why?
|
| Genes | 3 | 2001 | 491 | 0.070 |
Why?
|
| In Situ Hybridization, Fluorescence | 4 | 2005 | 2232 | 0.070 |
Why?
|
| Fenretinide | 1 | 2005 | 96 | 0.070 |
Why?
|
| Chromosomes, Artificial, Yeast | 2 | 2002 | 40 | 0.070 |
Why?
|
| Genetic Markers | 4 | 2020 | 974 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 15 | 2 | 1997 | 231 | 0.060 |
Why?
|
| Genes, Wilms Tumor | 1 | 2005 | 64 | 0.060 |
Why?
|
| Protein Kinase C | 1 | 2007 | 396 | 0.060 |
Why?
|
| Tauopathies | 1 | 2005 | 63 | 0.060 |
Why?
|
| Checkpoint Kinase 2 | 1 | 2005 | 126 | 0.060 |
Why?
|
| Cyclooxygenase 2 | 1 | 2007 | 483 | 0.060 |
Why?
|
| Interleukin-8 | 1 | 2007 | 519 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 2 | 2010 | 3101 | 0.060 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2001 | 6915 | 0.060 |
Why?
|
| Aged | 15 | 2013 | 70117 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 17 | 3 | 2003 | 641 | 0.060 |
Why?
|
| Muscle, Smooth | 2 | 2002 | 236 | 0.060 |
Why?
|
| tau Proteins | 1 | 2005 | 216 | 0.060 |
Why?
|
| Hybrid Cells | 4 | 1996 | 128 | 0.060 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2004 | 182 | 0.060 |
Why?
|
| Anticarcinogenic Agents | 1 | 2005 | 362 | 0.060 |
Why?
|
| Proteins | 2 | 2009 | 1963 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 1439 | 0.060 |
Why?
|
| Transfection | 3 | 2007 | 2944 | 0.060 |
Why?
|
| Introns | 1 | 2004 | 432 | 0.060 |
Why?
|
| Ataxia | 1 | 2004 | 176 | 0.060 |
Why?
|
| Radionuclide Imaging | 1 | 2004 | 660 | 0.060 |
Why?
|
| Signal Transduction | 3 | 2017 | 11965 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 3 | 2011 | 1077 | 0.050 |
Why?
|
| Wilms Tumor | 1 | 2005 | 292 | 0.050 |
Why?
|
| Breast | 1 | 2009 | 1344 | 0.050 |
Why?
|
| Receptors, Vasoactive Intestinal Polypeptide, Type I | 1 | 2001 | 8 | 0.050 |
Why?
|
| CCCTC-Binding Factor | 1 | 2021 | 33 | 0.050 |
Why?
|
| Child, Preschool | 7 | 2020 | 16273 | 0.050 |
Why?
|
| Reference Values | 2 | 2001 | 1099 | 0.050 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 2007 | 239 | 0.050 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2004 | 332 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2005 | 644 | 0.050 |
Why?
|
| Neurodegenerative Diseases | 1 | 2004 | 264 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2009 | 1491 | 0.050 |
Why?
|
| CHO Cells | 3 | 2000 | 311 | 0.050 |
Why?
|
| Cell Line, Tumor | 4 | 2011 | 14551 | 0.050 |
Why?
|
| Genome | 1 | 2005 | 672 | 0.050 |
Why?
|
| Personality Disorders | 1 | 2003 | 164 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2014 | 1062 | 0.050 |
Why?
|
| Neurons | 2 | 2017 | 2287 | 0.050 |
Why?
|
| Sequence Alignment | 4 | 2009 | 844 | 0.050 |
Why?
|
| United States | 3 | 2010 | 15433 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2009 | 1823 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 7702 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2010 | 2488 | 0.050 |
Why?
|
| Cystatins | 2 | 1998 | 15 | 0.050 |
Why?
|
| Intrinsic Factor | 1 | 2000 | 3 | 0.050 |
Why?
|
| Heterozygote | 3 | 2011 | 1020 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2008 | 1399 | 0.050 |
Why?
|
| Cricetinae | 3 | 2000 | 706 | 0.050 |
Why?
|
| Biomarkers, Tumor | 2 | 2010 | 10331 | 0.050 |
Why?
|
| Supratentorial Neoplasms | 1 | 2001 | 78 | 0.050 |
Why?
|
| Least-Squares Analysis | 1 | 2020 | 66 | 0.050 |
Why?
|
| Young Adult | 4 | 2013 | 21445 | 0.050 |
Why?
|
| Biostatistics | 1 | 2020 | 20 | 0.050 |
Why?
|
| Genes, p53 | 1 | 2005 | 1090 | 0.050 |
Why?
|
| Chromosome Breakage | 1 | 2001 | 226 | 0.050 |
Why?
|
| Vitamin B 12 | 1 | 2000 | 73 | 0.050 |
Why?
|
| Growth Disorders | 1 | 2002 | 218 | 0.050 |
Why?
|
| DNA-Binding Proteins | 3 | 2000 | 4821 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2008 | 2086 | 0.050 |
Why?
|
| Tubulin | 1 | 2000 | 169 | 0.050 |
Why?
|
| Leukemia, Myelomonocytic, Acute | 1 | 2000 | 72 | 0.050 |
Why?
|
| Proto-Oncogenes | 1 | 2000 | 202 | 0.040 |
Why?
|
| Polyadenylation | 1 | 2020 | 70 | 0.040 |
Why?
|
| Myoblasts | 2 | 2010 | 72 | 0.040 |
Why?
|
| Databases, Nucleic Acid | 1 | 2020 | 117 | 0.040 |
Why?
|
| Binding Sites | 3 | 2011 | 2171 | 0.040 |
Why?
|
| Child | 8 | 2020 | 29154 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2003 | 1064 | 0.040 |
Why?
|
| Apolipoprotein A-I | 1 | 1999 | 84 | 0.040 |
Why?
|
| Corneal Diseases | 1 | 2000 | 89 | 0.040 |
Why?
|
| Adolescent | 8 | 2020 | 31252 | 0.040 |
Why?
|
| Proteoglycans | 1 | 2000 | 259 | 0.040 |
Why?
|
| Genes, BRCA2 | 1 | 2001 | 309 | 0.040 |
Why?
|
| Antigens, CD34 | 1 | 2001 | 593 | 0.040 |
Why?
|
| Cerebellar Neoplasms | 2 | 2001 | 434 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2008 | 4844 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 2007 | 2819 | 0.040 |
Why?
|
| MEF2 Transcription Factors | 3 | 2010 | 47 | 0.040 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2000 | 159 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2001 | 598 | 0.040 |
Why?
|
| Lipoproteins, HDL | 1 | 1999 | 144 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2010 | 3343 | 0.040 |
Why?
|
| Medulloblastoma | 2 | 2001 | 540 | 0.040 |
Why?
|
| Brain | 4 | 2005 | 4113 | 0.040 |
Why?
|
| Genes, myc | 1 | 2000 | 358 | 0.040 |
Why?
|
| Eye Proteins | 1 | 2000 | 269 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2001 | 875 | 0.040 |
Why?
|
| Endocytosis | 1 | 1999 | 225 | 0.040 |
Why?
|
| Cognition Disorders | 1 | 2003 | 786 | 0.040 |
Why?
|
| Pentamidine | 1 | 2017 | 9 | 0.040 |
Why?
|
| Mice | 6 | 2018 | 34495 | 0.040 |
Why?
|
| Organ Specificity | 4 | 2002 | 699 | 0.040 |
Why?
|
| Transcriptome | 2 | 2018 | 1859 | 0.040 |
Why?
|
| Machine Learning | 1 | 2020 | 319 | 0.040 |
Why?
|
| Disease Models, Animal | 4 | 2017 | 7222 | 0.040 |
Why?
|
| Gene Amplification | 1 | 2000 | 731 | 0.040 |
Why?
|
| Photoreceptor Cells, Invertebrate | 1 | 2017 | 55 | 0.040 |
Why?
|
| Mutation, Missense | 2 | 2018 | 1152 | 0.040 |
Why?
|
| Mice, Inbred Strains | 1 | 2018 | 521 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 4 | 2009 | 5395 | 0.040 |
Why?
|
| Age Factors | 2 | 2020 | 5377 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2001 | 943 | 0.040 |
Why?
|
| Genes, Dominant | 1 | 1997 | 331 | 0.040 |
Why?
|
| Reward | 1 | 2017 | 169 | 0.040 |
Why?
|
| Linkage Disequilibrium | 3 | 2004 | 460 | 0.030 |
Why?
|
| eIF-2 Kinase | 1 | 2017 | 164 | 0.030 |
Why?
|
| Dinucleoside Phosphates | 1 | 1995 | 19 | 0.030 |
Why?
|
| Integrin-Binding Sialoprotein | 1 | 2015 | 15 | 0.030 |
Why?
|
| Hearing Loss | 1 | 1997 | 153 | 0.030 |
Why?
|
| Acute Disease | 1 | 2001 | 2422 | 0.030 |
Why?
|
| Rats | 2 | 2001 | 6086 | 0.030 |
Why?
|
| Fluoresceins | 1 | 2015 | 73 | 0.030 |
Why?
|
| Nigeria | 1 | 1995 | 74 | 0.030 |
Why?
|
| Cornea | 1 | 2000 | 638 | 0.030 |
Why?
|
| Genes, Homeobox | 1 | 1995 | 147 | 0.030 |
Why?
|
| 3T3 Cells | 1 | 2015 | 355 | 0.030 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 1997 | 192 | 0.030 |
Why?
|
| Cataract | 1 | 1997 | 218 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2015 | 142 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1996 | 254 | 0.030 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 1997 | 244 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2015 | 141 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 1996 | 244 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 4971 | 0.030 |
Why?
|
| Organic Anion Transporters | 1 | 2014 | 21 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2018 | 1313 | 0.030 |
Why?
|
| Nedd4 Ubiquitin Protein Ligases | 1 | 2014 | 23 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 2000 | 1910 | 0.030 |
Why?
|
| Neoplasms | 2 | 2011 | 15193 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2015 | 204 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 1995 | 259 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2001 | 2218 | 0.030 |
Why?
|
| Hypogonadism | 1 | 1997 | 257 | 0.030 |
Why?
|
| Myosin Heavy Chains | 2 | 2005 | 128 | 0.030 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2013 | 38 | 0.030 |
Why?
|
| Retina | 1 | 2017 | 532 | 0.030 |
Why?
|
| Emotions | 1 | 2017 | 562 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2011 | 4298 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 6009 | 0.030 |
Why?
|
| Infant, Newborn | 3 | 2011 | 8223 | 0.030 |
Why?
|
| Bone Neoplasms | 1 | 2005 | 2576 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2013 | 568 | 0.030 |
Why?
|
| Cell Movement | 2 | 2011 | 2466 | 0.030 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 840 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2010 | 1643 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 1538 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 2014 | 235 | 0.030 |
Why?
|
| Testis | 1 | 1996 | 717 | 0.030 |
Why?
|
| Netherlands | 1 | 2011 | 83 | 0.020 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2013 | 244 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2009 | 10035 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 663 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 482 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 2017 | 858 | 0.020 |
Why?
|
| Ornithine Decarboxylase | 1 | 2010 | 31 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 1217 | 0.020 |
Why?
|
| RNA Caps | 1 | 2010 | 34 | 0.020 |
Why?
|
| Contig Mapping | 2 | 2000 | 61 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 1995 | 1143 | 0.020 |
Why?
|
| Codon | 1 | 2010 | 241 | 0.020 |
Why?
|
| 5' Untranslated Regions | 1 | 2010 | 93 | 0.020 |
Why?
|
| Nogo Proteins | 1 | 2009 | 11 | 0.020 |
Why?
|
| LIM Domain Proteins | 1 | 2010 | 104 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 3719 | 0.020 |
Why?
|
| Genetics, Population | 1 | 2011 | 242 | 0.020 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2011 | 173 | 0.020 |
Why?
|
| Tripartite Motif Proteins | 1 | 2009 | 55 | 0.020 |
Why?
|
| 5' Flanking Region | 1 | 2009 | 21 | 0.020 |
Why?
|
| Ribosomes | 1 | 2010 | 147 | 0.020 |
Why?
|
| Actin Cytoskeleton | 1 | 2009 | 82 | 0.020 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2009 | 92 | 0.020 |
Why?
|
| Myelin Proteins | 1 | 2009 | 90 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2014 | 986 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2010 | 760 | 0.020 |
Why?
|
| BRCA2 Protein | 2 | 2001 | 358 | 0.020 |
Why?
|
| Germany | 1 | 2008 | 111 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 2 | 2011 | 2403 | 0.020 |
Why?
|
| Fibroblasts | 1 | 1995 | 1682 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 2 | 2007 | 3981 | 0.020 |
Why?
|
| Cystatin B | 2 | 1998 | 6 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2011 | 9244 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2010 | 5637 | 0.020 |
Why?
|
| Ovarian Neoplasms | 2 | 2001 | 4638 | 0.020 |
Why?
|
| Histones | 1 | 2015 | 1466 | 0.020 |
Why?
|
| Morphogenesis | 1 | 2009 | 337 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2000 | 383 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 1996 | 2022 | 0.020 |
Why?
|
| Epithelial Cells | 2 | 2009 | 1818 | 0.020 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 1 | 2007 | 24 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2009 | 652 | 0.020 |
Why?
|
| Microfilament Proteins | 2 | 2002 | 487 | 0.020 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2007 | 58 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2009 | 1008 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2000 | 997 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1997 | 354 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2009 | 589 | 0.020 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2007 | 110 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2007 | 256 | 0.020 |
Why?
|
| Nitrogen Oxides | 1 | 2005 | 15 | 0.020 |
Why?
|
| Neurofibrillary Tangles | 1 | 2005 | 24 | 0.020 |
Why?
|
| Incidence | 2 | 2010 | 5673 | 0.020 |
Why?
|
| Nitric Oxide Donors | 1 | 2005 | 51 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2007 | 426 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 2139 | 0.020 |
Why?
|
| Prenatal Diagnosis | 1 | 2000 | 590 | 0.020 |
Why?
|
| Inclusion Bodies | 1 | 2005 | 76 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2007 | 360 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2005 | 249 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2015 | 5710 | 0.020 |
Why?
|
| RNA Interference | 1 | 2010 | 1408 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2005 | 334 | 0.020 |
Why?
|
| Ophthalmoplegia, Chronic Progressive External | 1 | 2004 | 5 | 0.020 |
Why?
|
| DNA Polymerase gamma | 1 | 2004 | 15 | 0.020 |
Why?
|
| Syndrome | 2 | 1999 | 1351 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2005 | 4744 | 0.020 |
Why?
|
| Scandinavian and Nordic Countries | 1 | 2004 | 2 | 0.020 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 314 | 0.020 |
Why?
|
| Electrophoresis, Capillary | 1 | 2004 | 31 | 0.020 |
Why?
|
| Middle East | 1 | 2004 | 46 | 0.020 |
Why?
|
| Electromyography | 1 | 2005 | 226 | 0.020 |
Why?
|
| Consanguinity | 1 | 2004 | 114 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 5178 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2008 | 509 | 0.010 |
Why?
|
| Occipital Lobe | 1 | 2003 | 48 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2009 | 1620 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 2003 | 121 | 0.010 |
Why?
|
| Hydrazines | 1 | 2005 | 208 | 0.010 |
Why?
|
| Parietal Lobe | 1 | 2003 | 66 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2007 | 1391 | 0.010 |
Why?
|
| Intestinal Absorption | 1 | 2004 | 211 | 0.010 |
Why?
|
| Epitopes | 1 | 2005 | 685 | 0.010 |
Why?
|
| Protein Binding | 1 | 2010 | 3438 | 0.010 |
Why?
|
| Prevalence | 1 | 2011 | 3260 | 0.010 |
Why?
|
| DNA, Mitochondrial | 1 | 2004 | 311 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 2003 | 187 | 0.010 |
Why?
|
| Tandem Repeat Sequences | 1 | 2003 | 201 | 0.010 |
Why?
|
| Infant | 2 | 2011 | 13310 | 0.010 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2003 | 305 | 0.010 |
Why?
|
| Ribonucleases | 1 | 2002 | 88 | 0.010 |
Why?
|
| Iceland | 1 | 2001 | 12 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 4757 | 0.010 |
Why?
|
| Point Mutation | 1 | 2004 | 769 | 0.010 |
Why?
|
| Geography | 1 | 2001 | 140 | 0.010 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2001 | 68 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 2001 | 117 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 2045 | 0.010 |
Why?
|
| Human Genome Project | 1 | 2001 | 64 | 0.010 |
Why?
|
| Epidemiologic Studies | 1 | 2001 | 60 | 0.010 |
Why?
|
| Penetrance | 1 | 2001 | 126 | 0.010 |
Why?
|
| Expressed Sequence Tags | 1 | 2000 | 101 | 0.010 |
Why?
|
| Artificial Gene Fusion | 1 | 2000 | 18 | 0.010 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2000 | 24 | 0.010 |
Why?
|
| Surface Plasmon Resonance | 1 | 2000 | 105 | 0.010 |
Why?
|
| Pseudogenes | 1 | 2000 | 81 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 2003 | 471 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 6207 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2002 | 1037 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 29902 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2000 | 682 | 0.010 |
Why?
|
| Hippocampus | 1 | 2005 | 915 | 0.010 |
Why?
|
| Leupeptins | 1 | 1999 | 68 | 0.010 |
Why?
|
| Chloroquine | 1 | 1999 | 53 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1999 | 122 | 0.010 |
Why?
|
| Norway | 1 | 1999 | 30 | 0.010 |
Why?
|
| Saudi Arabia | 1 | 1999 | 39 | 0.010 |
Why?
|
| Yolk Sac | 1 | 1999 | 26 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2000 | 234 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2003 | 1178 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2000 | 611 | 0.010 |
Why?
|
| Malabsorption Syndromes | 1 | 1999 | 55 | 0.010 |
Why?
|
| Phylogeny | 1 | 2001 | 826 | 0.010 |
Why?
|
| Dog Diseases | 1 | 1999 | 73 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2020 | 32848 | 0.010 |
Why?
|
| Urine | 1 | 1999 | 143 | 0.010 |
Why?
|
| Leucine | 1 | 2000 | 352 | 0.010 |
Why?
|
| Indoles | 1 | 2004 | 1009 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2000 | 931 | 0.010 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2000 | 197 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1999 | 562 | 0.010 |
Why?
|
| Dogs | 1 | 1999 | 1155 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1999 | 371 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 4938 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2003 | 1171 | 0.010 |
Why?
|
| Lod Score | 1 | 1997 | 157 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2009 | 10001 | 0.010 |
Why?
|
| Time Factors | 2 | 2001 | 12926 | 0.010 |
Why?
|
| Homozygote | 1 | 1999 | 717 | 0.010 |
Why?
|
| Collagen | 1 | 2000 | 752 | 0.010 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2000 | 461 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 1997 | 185 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2001 | 1070 | 0.010 |
Why?
|
| Family | 1 | 2000 | 736 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 2001 | 1005 | 0.010 |
Why?
|
| Antibodies | 1 | 1999 | 838 | 0.010 |
Why?
|
| Centromere | 1 | 1995 | 97 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2000 | 1073 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2001 | 1245 | 0.010 |
Why?
|
| Remission Induction | 1 | 2001 | 3569 | 0.010 |
Why?
|
| Gene Library | 1 | 1995 | 294 | 0.010 |
Why?
|
| Computational Biology | 1 | 2001 | 1271 | 0.010 |
Why?
|
| Risk Factors | 1 | 2011 | 17523 | 0.010 |
Why?
|
| alpha-Mannosidase | 1 | 1993 | 3 | 0.010 |
Why?
|
| Dipeptidases | 1 | 1993 | 16 | 0.010 |
Why?
|
| Glucose-6-Phosphate Isomerase | 1 | 1993 | 24 | 0.010 |
Why?
|
| Mannosidases | 1 | 1993 | 19 | 0.010 |
Why?
|
| Cricetulus | 1 | 1993 | 205 | 0.010 |
Why?
|
| Intestines | 1 | 1996 | 686 | 0.010 |
Why?
|
| Prognosis | 1 | 2009 | 21713 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1993 | 614 | 0.010 |
Why?
|
| Kidney | 1 | 1999 | 2146 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 1996 | 1081 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1993 | 1546 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 1999 | 6100 | 0.010 |
Why?
|
| Myocardium | 1 | 1995 | 1313 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 1993 | 1960 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 1997 | 2195 | 0.000 |
Why?
|